Pharma BD Deal Intelligence
Lexicon Genetics Incorporated / Coelacanth Corporation
2001 · Acquisition/Merger · $32M · Complete
Announcement Sentiment
75
Strongly positive
Stock-for-stock; created Lexicon Pharmaceuticals. Below $250M threshold but strategically notable: chemistry/ADME platform; Coelacanth clients included Pfizer, Roche, Novartis.
Key facts
- Announced Jun 13, 2001
- Deal value $32M
- Deal type Acquisition/Merger
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals